GHK-Cu Anti-Inflammatory refers to the capacity of the copper-binding peptide Glycyl-L-Histidyl-L-Lysine (GHK-Cu) to modulate and reduce excessive inflammatory signaling within tissues. This tripeptide, naturally found in human plasma, decreases the production of pro-inflammatory cytokines and suppresses the activity of key inflammatory transcription factors. This anti-inflammatory action is crucial for tissue repair, skin health, and systemic longevity by mitigating the effects of chronic low-grade inflammation.
Origin
GHK was first isolated from human plasma in the 1970s, and its affinity for copper led to the complex GHK-Cu. The ‘Anti-Inflammatory’ designation emerged from subsequent molecular research that characterized its gene-modulating effects beyond its initial discovery as a wound-healing agent. Its role in modulating the immune response places it as a key molecule in regenerative medicine.
Mechanism
The mechanism involves GHK-Cu’s ability to regulate the expression of hundreds of genes, many of which are involved in inflammation and tissue repair. It actively suppresses the expression of key inflammatory mediators, such as NF-κB and various interleukins, while simultaneously upregulating anti-oxidant enzymes. By acting as a signaling molecule, GHK-Cu helps to shift the cellular environment from a pro-inflammatory, catabolic state to a regenerative, anabolic state, facilitating healing and reducing chronic tissue damage.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.